Swiss Re Insurance-Linked Fund Management

Original Risk: A Society for Change Agents

Bellemeade Re, AIG’s ILS for mortgage insurance risks, completes


American International Group (AIG) has completed a unique (in recent times) insurance-linked securities (ILS) transaction named Bellemeade Re Ltd., which transfers some of its mortgage insurance portfolio risks to capital market investors.

The transaction, which listed on the Bermuda Stock Exchange (BSX) on the 29th July, is essentially an ILS or capital markets based reinsurance securitization deal, not a mortgage loan securitization like those that gained such a tainted profile during the financial crisis.

It is not securitizing mortgage loans or credit risk, as has been reported elsewhere in the financial press, rather it provides reinsurance protection to AIG subsidiary United Guaranty Corporation for the risk of seeing a dramatic increase in mortgage insurance payouts.

The deal does mean that United Guaranty has transferred risks that are ultimately linked to the default rates on the mortgage loans it provides, of course, as the insurance policies pay out when a borrower defaults or cannot make a repayment.

United Guaranty, ultimately the cedent or sponsor here, largely provides mortgage insurance to borrowers who do not have large deposits to put down on homes, hence some of the mortgage population in the U.S. that could be considered higher risk, or less prime.

As a result, with a large portfolio of insurance policies that pay out when homeowners default on mortgage payments or miss payments and make a claim on their mortgage insurance, United Guaranty and AIG need reinsurance capacity for that exposure.

Bellemeade Re Ltd. is a Bermuda domiciled special purpose insurance (SPI) vehicle that was registered in June, designed to facilitate a collateralized reinsurance transaction for United Guaranty and AIG, through the securitization of the risk and sale of notes to investors.

Bellemeade Re entered into a reinsurance agreement with United Guaranty, which will see it assume the mortgage insurance loss risks associated with an insurance portfolio for mortgage loans amounting to around $32.4 billion.

Bellemeade Re has issued and sold $298.89m of Series 2015-1 insurance-linked notes to investors, transferring the risk of mortgage insurance losses on to them and receiving collateralized reinsurance protection in return. The notes are said to cover a percentage of losses within layers of the mortgage insurance portfolio.

It’s important to understand that it’s the risk of AIG subsidiary United Guaranty suffering mortgage insurance losses, above a specified attachment level, associated with these loans that is being reinsured and transferred, not the loans themselves or loan repayment risks.

As the Bellemeade Re structure is a typical ILS, effectively the same as a property catastrophe bond, the Bellemeade Re notes feature a trigger. The deal has been structured as an indemnity bond, with three different payout levels and three tranches of notes issued.

This Series 2015-1 issuance from Bellemeade Re Ltd. involved the issuance of a $14.429m Class B-1 tranche, a $140.168m Class M-1 tranche and a $144.291m Class M-2 tranche of notes.

The three tranches of notes have been collateralized with highly rated U.S. Treasury funds, we understand, as is typical of ILS transactions.

Investors are taking on the risk that United Guaranty suffers mortgage insurance losses above a certain level during each risk period. At this time we don’t have any details on the attachment levels or the probabilities of attachment and expected losses associated with the notes.

So this is an indemnity reinsurance transaction, with any losses to be borne by the capital markets investors in the Bellemeade Re notes tied to the amount of mortgage insurance losses suffered.

The notes will provide fully-collateralized reinsurance protection for United Guaranty’s mortgage insurance risks. The collateral will be held in trust, as with all ILS and cat bond deals.

We’re told that AIG itself and BNP Paribas acted as co-managers for this transaction, while Credit Suisse was the sole bookrunner.

That’s all the detail we’ve managed to glean to date. It’s possible that more information will become available in the days to come.

As part of AIG’s strategic restructuring of its reinsurance and growing use of capital markets and ILS transactions this Bellemeade Re transaction breaks new ground, being the first ILS to transfer mortgage insurance risks that we’ve seen from the sponsor.

We understand that the Bellemeade Re notes were broadly marketed, but predominantly to investors who would understand mortgage insurance risk meaning that much of the ILS market may not have seen this deal.

The Bellemeade Re Ltd. transaction was placed as a standard Rule 144a offering to a broad group of money managers and mortgage specialist hedge funds, we understand.

Given the underlying risks are mortgage insurance losses this Bellemeade Re ILS deal wouldn’t have been attractive to all investors anyway. However it may have proved so for some ILS investors looking for a new diversifying risk for their portfolios.

Given this is an ILS deal, we’ve added Bellemeade Re Ltd. (Series 2015-1) into the Artemis Deal Directory. We’ll update you should further information become available.

Update: We understand from contacts that there have been a number of previous transactions which have securitized mortgage insurance policy risks, with MGIC’s Home Re and Radian’s SHome (Smart Home), both being transactions from the mid-2000’s which achieved a similar goal to Bellemeade Re.

Register today for ILS NYC 2023, our next insurance-linked securities (ILS) market conference. Held in New York City, February 10th, 2023.

Artemis ILS NYC 2023 - Insurance-linked securities conference in New York City

Get a ticket soon to ensure you can attend. Secure your place at the event here!

Print Friendly, PDF & Email

Artemis Newsletters and Email Alerts

Receive a regular weekly email newsletter update containing all the top news stories, deals and event information

  • This field is for validation purposes and should be left unchanged.

Receive alert notifications by email for every article from Artemis as it gets published.